A Rapid Derivative Spectrophotometric Method for Simultaneous Determination of Naphazoline and Antazoline in Eye Drops
A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, resp...
Saved in:
Published in: | Chemical & Pharmaceutical Bulletin Vol. 54; no. 1; pp. 119 - 122 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Japan
The Pharmaceutical Society of Japan
2006
Pharmaceutical Society of Japan Japan Science and Technology Agency |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (r2>0.999) in the range of 0.2—1 μg/ml for naphazoline hydrochloride in the presence of 5 μg/ml antazoline phosphate at 225 nm. The same linear correlation (r2>0.999) was obtained in the range of 1—10 μg/ml of antazoline phosphate in the presence of 0.5 μg/ml of naphazoline hydrochloride at 252 nm. The limit of determination was 0.2 μg/ml and 1 μg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis. |
---|---|
AbstractList | A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (r2>0.999) in the range of 0.2—1 μg/ml for naphazoline hydrochloride in the presence of 5 μg/ml antazoline phosphate at 225 nm. The same linear correlation (r2>0.999) was obtained in the range of 1—10 μg/ml of antazoline phosphate in the presence of 0.5 μg/ml of naphazoline hydrochloride at 252 nm. The limit of determination was 0.2 μg/ml and 1 μg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis. A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (γ2>0.999) in the range of 0.2-1μg/ml for naphazoline hydrochloride in the presence of 5μg/ml antazoline phosphate at 225 nm. The same linear correlation (γ2>0.999) was obtained in the range of 110μg/ml of antazoline phosphate in the presence of 0.5μg/ml of, naphazoline hydrochloride at 252 nm. The limit of determination was 0.2μg/ml and 1μg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis. A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (r2>0.999) in the range of 0.2-1 microg/ml for naphazoline hydrochloride in the presence of 5 microg/ml antazoline phosphate at 225 nm. The same linear correlation (r2>0.999) was obtained in the range of 1-10 microg/ml of antazoline phosphate in the presence of 0.5 microg/ml of naphazoline hydrochloride at 252 nm. The limit of determination was 0.2 microg/ml and 1 microg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis. A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (r2>0.999) in the range of 0.2-1 microg/ml for naphazoline hydrochloride in the presence of 5 microg/ml antazoline phosphate at 225 nm. The same linear correlation (r2>0.999) was obtained in the range of 1-10 microg/ml of antazoline phosphate in the presence of 0.5 microg/ml of naphazoline hydrochloride at 252 nm. The limit of determination was 0.2 microg/ml and 1 microg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis. |
Author | Afshari, Alma Farsam, Hassan Souri, Effat Amanlou, Massoud |
Author_xml | – sequence: 1 fullname: Souri, Effat organization: Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences – sequence: 2 fullname: Amanlou, Massoud organization: Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences – sequence: 3 fullname: Farsam, Hassan organization: Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences – sequence: 4 fullname: Afshari, Alma organization: Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16394564$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkU2LFDEQhoOsuLOrF3-ABAQPwoz56nT6JMN-qLAquHoO6XS1k6E76U0yA-uvN0OPs-ClkqKeeuul6gKd-eABodeUrCgT6oOd2lUlVpQ2z9CCclEvK8b4GVoQQpol45Kfo4uUtoSwitT8BTqnkjeikmKB9mv8w0yuw9cQ3d5ktwd8P4HNMUybkMMIOTqLv0LehA73IeJ7N-6GbDyEXSpdGeLofGkMHocefzPTxvwJg_OAje_w2ud_qfP45hHwdVFOL9Hz3gwJXh3fS_Tr9ubn1efl3fdPX67Wd0srlchLaBgoxTomWUt7rkgniQTJlax5K0BJ0jMiW1UzEKxljNqqrnjfW1qzRtmKX6J3s-4Uw8MOUtajSxaGYfavZS1JwxpSwLf_gduwi75401RIwlWtxIF6P1M2hpQi9HqKbjTxUVOiD7fQ5Ra6ErrcosBvjpK7doTuCT0uvwC3M1Cqzpoh-MOengbbVNsNjE4zQqQmpBKEasLKt8iXIBkr1quDrY-z0DZl8xtOk0zMzg5wMjWHQ_OpsjFRg-d_AT5Hsw4 |
CitedBy_id | crossref_primary_10_1016_j_aca_2008_12_039 crossref_primary_10_1039_C5NJ03334A crossref_primary_10_1039_C0AN00343C crossref_primary_10_1007_s10895_009_0526_3 crossref_primary_10_5402_2012_917879 crossref_primary_10_1007_s10847_007_9377_1 crossref_primary_10_1186_s13065_022_00819_9 crossref_primary_10_18596_jotcsa_450793 crossref_primary_10_1016_S1452_3981_23_16275_4 crossref_primary_10_3892_mmr_2016_4937 crossref_primary_10_1080_10826076_2012_668736 crossref_primary_10_1016_j_microc_2024_110702 crossref_primary_10_1080_10826070802711113 crossref_primary_10_1002_bio_1297 crossref_primary_10_1016_j_rechem_2023_100920 crossref_primary_10_1016_j_jchromb_2013_04_021 crossref_primary_10_1016_j_jpha_2013_03_008 crossref_primary_10_1186_1752_153X_8_7 crossref_primary_10_1134_S1061934815030041 crossref_primary_10_1016_j_ijleo_2019_164010 crossref_primary_10_1038_s41598_023_46940_0 crossref_primary_10_1080_10826076_2013_789802 crossref_primary_10_1039_D0RA10598H |
Cites_doi | 10.1016/S0731-7085(01)00394-6 10.1016/S0731-7085(01)00627-6 10.1002/jps.2600680920 10.1016/S0731-7085(03)00347-9 10.1002/jps.2600670143 10.1016/S0731-7085(00)00596-3 10.1016/S0731-7085(01)00428-9 10.1111/j.2042-7158.1972.tb09050.x 10.1016/S0731-7085(01)00556-8 10.1016/S0731-7085(01)00664-1 10.1016/S0731-7085(03)00429-1 10.1016/S0731-7085(00)00600-2 10.1016/S0731-7085(02)00065-1 10.1016/S0731-7085(01)00388-0 10.1016/S0731-7085(01)00583-0 10.1016/S0731-7085(02)00095-X 10.1016/S0731-7085(01)00474-5 10.1002/jps.2600840422 |
ContentType | Journal Article |
Copyright | 2006 The Pharmaceutical Society of Japan Copyright Japan Science and Technology Agency 2006 |
Copyright_xml | – notice: 2006 The Pharmaceutical Society of Japan – notice: Copyright Japan Science and Technology Agency 2006 |
CorporateAuthor | Faculty of Pharmacy and Pharmaceutical Sciences Research Center University of Medical Sciences Department of Medicinal Chemistry |
CorporateAuthor_xml | – name: Department of Medicinal Chemistry – name: Faculty of Pharmacy and Pharmaceutical Sciences Research Center University of Medical Sciences |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7TM 7U9 H94 7X8 |
DOI | 10.1248/cpb.54.119 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Virology and AIDS Abstracts Neurosciences Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1347-5223 |
EndPage | 122 |
ExternalDocumentID | 3133608961 10_1248_cpb_54_119 16394564 cs7chemi_2006_005401_026_0119_0162229050 article_cpb_54_1_54_1_119_article_char_en |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 29B 2WC 3O- 53G 5GY 6J9 AABQG AAUGY ABTAH ACGFO ACIWK ACPRK ADBBV AENEX AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP CS3 DIK DU5 E3Z EBS EJD F5P GX1 HH5 JMI JSF JSH KQ8 L7B MOJWN OK1 P2P RJT RZJ TKC TR2 VH1 X7J X7M XSB ZE2 ZGI ZY4 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7TM 7U9 H94 7X8 |
ID | FETCH-LOGICAL-c684t-e92e882d262b1f380d606e638673b4e860f206b872e42b221c5753ffc17298c53 |
ISSN | 0009-2363 |
IngestDate | Fri Aug 16 05:21:00 EDT 2024 Thu Oct 10 17:39:17 EDT 2024 Fri Aug 23 01:40:40 EDT 2024 Sat Sep 28 08:39:17 EDT 2024 Fri Nov 08 06:52:50 EST 2024 Thu Aug 17 20:29:00 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c684t-e92e882d262b1f380d606e638673b4e860f206b872e42b221c5753ffc17298c53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/cpb/54/1/54_1_119/_article/-char/en |
PMID | 16394564 |
PQID | 1460387840 |
PQPubID | 1996362 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_67609290 proquest_journals_1460387840 crossref_primary_10_1248_cpb_54_119 pubmed_primary_16394564 medicalonline_journals_cs7chemi_2006_005401_026_0119_0162229050 jstage_primary_article_cpb_54_1_54_1_119_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2006 20060000 2006-Jan 2006-00-00 20060101 |
PublicationDateYYYYMMDD | 2006-01-01 |
PublicationDate_xml | – year: 2006 text: 2006 |
PublicationDecade | 2000 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Tokyo |
PublicationTitle | Chemical & Pharmaceutical Bulletin |
PublicationTitleAlternate | Chem. Pharm. Bull. |
PublicationYear | 2006 |
Publisher | The Pharmaceutical Society of Japan Pharmaceutical Society of Japan Japan Science and Technology Agency |
Publisher_xml | – name: The Pharmaceutical Society of Japan – name: Pharmaceutical Society of Japan – name: Japan Science and Technology Agency |
References | 15) El-Ragehy N. A., Badawey A. M., Elkhateeb S. Z., J. Pharm. Biomed. Anal., 28, 1041—1053 (2002). 17) Satana E., Altinay S., Gunden Gogea N., Ozkan S. A., Senturk Z., J. Pharm. Biomed. Anal., 25, 1009—1013 (2001). 1) Abdine H., Wahbi A. M., Korany M. A., J. Pharm. Pharmacol., 24, 522—524 (1972). 5) Ruckmick S. C., March D. F., Duong S. T., J. Pharm. Sci., 84, 502—507 (1995). 3) Boon P. F. G., Sudds W., J. Pharm. Pharmacol., 19, 88S—92S (1967). 19) Erk N., J. Pharm. Biomed. Anal., 28, 391—397 (2002). 21) Lastra O. C., Lemus I. G., Sanchez H. J., Perez R. F., J. Pharm. Biomed. Anal., 33, 175—180 (2003). 8) Erk N., J. Pharm. Biomed. Anal., 26, 43—52 (2001). 10) Castro D., Moreno M. A., Lastres J. L., J. Pharm. Biomed. Anal., 26, 563—572 (2001). 16) El-Gindy A., El-Zeany B., Awad T., Shabana M. M., J. Pharm. Biomed. Anal., 26, 203—210 (2001). 6) Karpinska J., Mulikowska M., J. Pharm. Biomed. Anal., 29, 53—58 (2002). 11) Trabelsi H., Raouafi F., Limam M., Bousouita K., J. Pharm. Biomed. Anal., 29, 239—245 (2002). 9) Vega E., Sola N., J. Pharm. Biomed. Anal., 25, 523—530 (2001). 4) Koziol T. R., Jacob J. T., Achari R. G., J. Pharm. Sci., 68, 1135—1138 (1979). 7) Senturk N., Erk S. A., Ozkan C., Akay S., J. Pharm. Biomed. Anal., 29, 291—298 (2002). 14) Hasan N. Y., Elkway M. A., Elzeany B. E., Wagieh N. E., J. Pharm. Biomed. Anal., 28, 187—197 (2002). 18) Prasad C. V. N., Parihar Ch., Chowdhary T. R., Purohit S., Parimoo P., Pharm. Pharmacol. Commun., 4, 325—330 (1998). 13) Ragno G., Garofalo A., Vetuschi C., J. Pharm. Biomed. Anal., 27, 19—24 (2002). 20) Markopoulou C. K., Koundourelllis J. E., J. Pharm. Biomed. Anal., 33, 1163—1173 (2003). 2) Wahbi A. M., Abdine H., Korany M. A., El-Yazbi F. A., J. Pharm. Sci., 67, 140—141 (1978). 12) Gungor S., Onur F., J. Pharm. Biomed. Anal., 25, 511—521 (2001). 11 Abdine H., Wahbi A. M., Korany M. A. (1) 1972; 24 12 Boon P. F. G., Sudds W. (3) 1967; 19 13 16 17 19 (4) 1979; 68 Hasan N. Y., Elkway M. A., Elzeany B. E., Wagieh N. E. (14) 2002; 28 Karpinska J., Mulikowska M. (6) 2002; 29 7 Prasad C. V. N., Parihar Ch., Chowdhary T. R., Purohit S., Parimoo P. (18) 1998; 4 8 9 (5) 1995; 84 Lastra O. C., Lemus I. G., Sanchez H. J., Perez R. F. (21) 2003; 33 Wahbi A. M., Abdine H., Korany M. A., El-Yazbi F. A. (2) 1978; 67 El-Ragehy N. A., Badawey A. M., Elkhateeb S. Z. (15) 2002; 28 20 10 |
References_xml | – ident: 17 doi: 10.1016/S0731-7085(01)00394-6 – ident: 19 doi: 10.1016/S0731-7085(01)00627-6 – volume: 68 start-page: 1135 issn: 0022-3549 issue: 9 year: 1979 ident: 4 publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600680920 – volume: 33 start-page: 175 issn: 0731-7085 year: 2003 ident: 21 publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/S0731-7085(03)00347-9 contributor: fullname: Lastra O. C., Lemus I. G., Sanchez H. J., Perez R. F. – volume: 67 start-page: 140 issn: 0022-3549 year: 1978 ident: 2 publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600670143 contributor: fullname: Wahbi A. M., Abdine H., Korany M. A., El-Yazbi F. A. – ident: 9 doi: 10.1016/S0731-7085(00)00596-3 – ident: 16 doi: 10.1016/S0731-7085(01)00428-9 – volume: 19 start-page: 88S issn: 0022-3573 year: 1967 ident: 3 publication-title: J. Pharm. Pharmacol. contributor: fullname: Boon P. F. G., Sudds W. – volume: 4 start-page: 325 year: 1998 ident: 18 publication-title: Pharm. Pharmacol. Commun. contributor: fullname: Prasad C. V. N., Parihar Ch., Chowdhary T. R., Purohit S., Parimoo P. – volume: 24 start-page: 522 issn: 0022-3573 year: 1972 ident: 1 publication-title: J. Pharm. Pharmacol. doi: 10.1111/j.2042-7158.1972.tb09050.x contributor: fullname: Abdine H., Wahbi A. M., Korany M. A. – ident: 13 doi: 10.1016/S0731-7085(01)00556-8 – volume: 28 start-page: 1041 issn: 0731-7085 year: 2002 ident: 15 publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/S0731-7085(01)00664-1 contributor: fullname: El-Ragehy N. A., Badawey A. M., Elkhateeb S. Z. – ident: 20 doi: 10.1016/S0731-7085(03)00429-1 – ident: 12 doi: 10.1016/S0731-7085(00)00600-2 – ident: 7 doi: 10.1016/S0731-7085(02)00065-1 – ident: 8 doi: 10.1016/S0731-7085(01)00388-0 – volume: 28 start-page: 187 issn: 0731-7085 year: 2002 ident: 14 publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/S0731-7085(01)00583-0 contributor: fullname: Hasan N. Y., Elkway M. A., Elzeany B. E., Wagieh N. E. – ident: 11 doi: 10.1016/S0731-7085(02)00095-X – volume: 29 start-page: 53 issn: 0731-7085 year: 2002 ident: 6 publication-title: J. Pharm. Biomed. Anal. contributor: fullname: Karpinska J., Mulikowska M. – ident: 10 doi: 10.1016/S0731-7085(01)00474-5 – volume: 84 start-page: 502 issn: 0022-3549 issue: 4 year: 1995 ident: 5 publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600840422 |
SSID | ssj0025073 ssib023156984 ssib014648066 ssib002822113 ssib017383858 |
Score | 1.9256036 |
Snippet | A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate... |
SourceID | proquest crossref pubmed medicalonline jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 119 |
SubjectTerms | Adrenergic alpha-Agonists - analysis Antazoline - analysis antazoline phosphate Anti-Allergic Agents - analysis Calibration derivative spectrophotometry eye drops Indicators and Reagents Naphazoline - analysis naphazoline hydrochloride Ophthalmic Solutions - analysis Reference Standards Reproducibility of Results Spectrophotometry, Ultraviolet |
Title | A Rapid Derivative Spectrophotometric Method for Simultaneous Determination of Naphazoline and Antazoline in Eye Drops |
URI | https://www.jstage.jst.go.jp/article/cpb/54/1/54_1_119/_article/-char/en http://mol.medicalonline.jp/en/journal/download?GoodsID=cs7chemi/2006/005401/026&name=0119-0162e https://www.ncbi.nlm.nih.gov/pubmed/16394564 https://www.proquest.com/docview/1460387840 https://search.proquest.com/docview/67609290 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Chemical and Pharmaceutical Bulletin, 2006, Vol.54(1), pp.119-122 |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Za9tAEF7StA-FUnrXbdoutOTFUaJjreOpiNohPeIEH9A3Ickr7NBIJrID7q_vN1odVkMhpRTDYuuypO_T7Hyr2RnGPni6MELHNbTQErom8ABpoRPFAAQfLzKlOaPJySdjZ_jd7Q_EYGenqqzZLPuvSGMZsKaZs3-Bdn1QLMB3YI4WqKO9Fe5-dxQuFxRefFUULruWRY351VW2nGer7JIqaMXd06JwdBFjOF5QUGGYSgqG7VfRMZUjOQyX8_BnVjijNMbup6vq5yLtDjay28eR820ft85BQKw6n7fGzFvZvsmRT5Jw1R2fTUf16O0p3PlsjX869YffzqaNicxz2KJjfzRughL8H5dh1z8en_jl_vX4Rc21306gilLFpX2Bn5C2rLanmVZpCEurrVJPt9ipTLBRmmDVmxvK1t_oKExBkx_iZXTYE4f1Lq3E23HuxHTDqFInxf7BtzUCSNaA0uShsakUuk7jRXdNWDkq3ND__HVby0Jc18YPPZJwt1LnG47lbicSgp_dsz2aNFyOFsBRr8sA0sWXuXVx4kfNabe8qXsXEBSUKeLBpXrJp5Kt_Fk7FT7U5BF7WIof7ivWPmY7F-ETtl8itDngk2YyYH7A9_l5k1d985Rd-7ygNm-ozW9Smytqc1Cbb1Obt6jNs4RvUZuD2ryhNl-kHNTmBbWfsenxYPLpRCvLhmix7YqVJj1TQjfOTNuMjMRy9RlEukQ_YztWJKRr64mp25HrmFKYEUCKIVmsJInhy3tu3LOes900S-VLxoVtWfQmHro_Er0wikJ4b70EGkZICVZ02Pvq9gdLlR0mIFUNkAKAFPQEFLbXYa5Cpt6mtA71NqohWtVrcINhzjrsYwvLoLQ0eXBbdnbYXoV-szPISGErrsDqd_VqdCz0tlChEtiOrUM7YYsXijPNFULVUBaqV_98cq_Z_WZIc4_trq7W8g27k8_Wb4uH6RdHA_fS |
link.rule.ids | 315,782,786,4030,27934,27935,27936 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Rapid+Derivative+Spectrophotometric+Method+for+Simultaneous+Determination+of+Naphazoline+and+Antazoline+in+Eye+Drops&rft.jtitle=Chemical+%26+Pharmaceutical+Bulletin&rft.au=Effat+SOURI&rft.au=Massoud+AMANLOU&rft.au=Hassan+FARSAM&rft.au=Alma+AFSHARI&rft.date=2006&rft.pub=Pharmaceutical+Society+of+Japan&rft.issn=0009-2363&rft.volume=54&rft.issue=1&rft.spage=119&rft.epage=162&rft_id=info:doi/10.1248%2Fcpb.54.119&rft.externalDocID=cs7chemi_2006_005401_026_0119_0162229050 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon |